Immunodiagnostics Market is predicted to reach USD 31.46 million by 2030 with a CAGR of 7.7% from 2021-2030

The Global Immunodiagnostics Market held USD 13.91 billion in 2019 and is predicted to reach USD 31.46 million by 2030 with a CAGR of 7.7% from 2020-2030.

Immunodiagnostics is a method to diagnose the disease on the basis of antigen-antibody reactions. It is a primary means for diagnosing infectious disease, chronic diseases such as cancer & cardiovascular diseases, autoimmunity diseases, and among others. It has enhanced the ability to target the areas to diagnose disease progression. The major advancement in immunodiagnostics has improved diagnosis of the complex interactive network. Also, the increase in incidence and prevalence of infectious diseases and growing awareness about immunodiagnostics has further increased the immunodiagnostics market size.

Access Full Description of this report at:-

https://www.nextmsc.com/report/immunodiagnostics-market

Competitive Landscape :

The immunodiagnostic market comprises of various market players such as Abbott Laboratories, Arkray Inc., bioMérieux SA, Immunodiagnostic Systems Holdings plc (IDS), Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche AG, Johnson & Johnson, Siemens AG, Sysmex Corporation and Thermo Fisher Scientific Inc. Strategic alliances, acquisitions and innovations along with various R&D activities are key strategies adopted by market players to maintain their dominance in the market. For instance, in September 2020, Immunodiagnostic Systems Holdings plc (IDS) launched four new i-Tracker assays designed to run on its automated IDS-iSYS analyser. It is a drug measuring kit, which measures the serum/plasma concentration of biological products used in the treatment of many inflammatory diseases. Also, in April 2021, DiaSorin launched LIAISON IQ reader and Immunodiagnostic PointofCare (POC). LIAISON IQ detects specific IgG antibodies against the SARSCoV2 spike protein in human capillary blood from a fingertip within 10 minutes.

Request free sample copy of this report at:-

https://www.nextmsc.com/Immunodiagnostics-Market/request-sample

Geographical Analysis:

North America region holds the largest immunodiagnostics market share in immunodiagnostics market and is anticipated to continue dominating the market during the forecast period. This is attributable to factors including demand for immunodiagnostics tests, increasing geriatric population, growing prevalence of chronic and infectious diseases, and high consumer awareness.

Asia-Pacific region is expected to grow with the highest CAGR during the forecast period owing to improvement in the public & private healthcare facility, favourable regulatory reforms, presence of large population pool, and prevalence of chronic diseases. Moreover, rising number of new product approvals and adequate reimbursement for tests and products are factors expected to accelerate the growth of immunodiagnostics market in this region.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.